Trial Profile
Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on long-term use in type 2 diabetes mellitus patients with renal or hepatic impairment or advanced age"
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Alogliptin/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda Pharma
- 12 Dec 2019 Status changed from active, no longer recruiting to completed.
- 06 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Jul 2018 Planned End Date changed from 30 Jun 2019 to 31 Oct 2019.